Related Experiment Video
Updated: Jul 6, 2026
09:23
Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
Published on: January 5, 2024
[New perspectives of the phage therapy]
L Eyer1, R Pantůcek, V Růzicková
1Oddelení genetiky a molekulární biologie, Mosarykova universzita, Brno.
Klinicka Mikrobiologie a Infekcni Lekarstvi
|March 6, 2008
Summary
Rational phage therapy offers a safe and effective alternative to antibiotics for combating antibiotic-resistant bacteria. This approach utilizes bacteriophages (phages) and their components to treat infections across human, veterinary, agricultural, and food industries.
Area of Science:
- Microbiology and infectious diseases
- Biotechnology and biopharmaceuticals
Context:
- Rising prevalence of antibiotic-resistant bacterial strains poses a significant global health threat.
- Traditional antibiotic therapies are becoming less effective and can cause adverse side effects.
- Bacteriophages (phages) have a long history of use in treating bacterial infections with minimal side effects.
Purpose:
- To explore rational phage therapy as a viable solution to antibiotic resistance.
- To highlight the potential of purified phage components for managing difficult-to-treat infections.
- To discuss the broad applicability of phage therapy in various sectors.
Summary:
- Phage therapy, utilizing bacteriophages (phages), presents a promising strategy against antibiotic-resistant bacteria.
- Current advancements focus on well-characterized, purified phage components, expanding therapeutic options.
- Effective against a range of bacteria including Enterococcus, Escherichia, Klebsiella, Listeria, Proteus, Pseudomonas, Salmonella, Shigella, Staphylococcus, and Streptococcus.
- Applications extend beyond human and veterinary medicine to agriculture and the food industry.
Impact:
- Phage therapy offers a safe and effective alternative to conventional antibiotic treatments.
- Clinical studies and animal models validate the efficacy of phage therapy.
- Potential to revolutionize infection management and mitigate the impact of antimicrobial resistance.
More Related Videos
07:22Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
Published on: August 19, 2021
08:46T4 Bacteriophage and E. coli Interaction in the Murine Intestine: A Prototypical Model for Studying Host-Bacteriophage Dynamics In Vivo
Published on: January 26, 2024
Related Concept Videos
01:30Lytic Cycle of Bacteriophages
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:23Bacteriophages of the Human Virome
Bacteriophages are found throughout the human body. They may even outnumber eukaryotic viruses, forming an important and dynamic component of the human virome. Indeed, phages represent the most abundant viral entities, with densities in the gut reaching up to 10⁹ particles per gram of fecal matter, and many belonging to orders such as Caudovirales and Microviridae, while a substantial proportion remains unclassified as viral “dark matter.”Lysogeny and Genetic ExchangeIn the gut, bacteriophages...
01:26DNA Bacteriophages
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
00:43Lysogenic Cycle of Bacteriophages
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
01:16Viral Replication: Lysogenic Cycle
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects its...